Stay updated with breaking news from Cell Stem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A method that malignant tumours use to remotely prevent the emergence of an immune response that would halt their growth has been discovered by researchers at Baylor College of Medicine and associated institutions.
Technology could potentially lead to faster genetic gains in beef or dairy production or to reducing disease incidence in the animals.
Researchers at Baylor College of Medicine and collaborating institutions have identified a strategy cancerous tumors use to remotely disrupt the development of an immune response that could stop their growth.
In a recent study published in the journal Cell Stem Cell, researchers hypothesized that pacemaker-like activity of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) resulted in engraftment arrhythmias (EAs), which hampers the clinical use of cell-based therapy using hPSC-CMs for treatment of myocardial infarction (MI).
Many patients deal with brain fog, extreme fatigue, and severe headaches